The distinction between adaptive and maladaptive muscle loss is central to understanding the quality, not just the quantity, of BW loss achieved with GLP-1 RA-based therapies [37, 38]
These include diabetic eye disease, a previous episode of pancreatitis, or advanced heart failure, where closer monitoring or alternative options may be more appropriate
Assets Download Contact Susan Cadrecha [email protected]
Remember, this is a journey, not a race
The Nuance of Action: Systemic vs
Your individual needs will differ, so the first step is a consultation and blood draw to determine your needs and outline a treatment plan that will work for you